지속성외래복막투석 환자에서 발생한 Achromobacter xylosoxidans에 의한 복막염 1예

Peritonitis is a major cause of morbidity in continuous ambulatory peritoneal dialysis (CAPD) patients. Achromobacter xylosoxidans is a rarely reported cause of peritonitis in CAPD patients. In this report, a peritonitis case due to Achromobacter xylosoxidans in a 60-year-old male patient with end-s...

Full description

Saved in:
Bibliographic Details
Published inKidney research and clinical practice Vol. 30; no. 2; pp. 215 - 219
Main Authors 전지민, Ji Min Jeon, 박용기, Yong Ki Park, 오준석, Joon Suk Oh, 김성민, Sung Min Kim, 신용훈, Yong Hun Sin, 김중경, Joong Kyung Kim
Format Journal Article
LanguageKorean
Published 대한신장학회 30.03.2011
Subjects
Online AccessGet full text
ISSN2211-9132
2211-9140

Cover

More Information
Summary:Peritonitis is a major cause of morbidity in continuous ambulatory peritoneal dialysis (CAPD) patients. Achromobacter xylosoxidans is a rarely reported cause of peritonitis in CAPD patients. In this report, a peritonitis case due to Achromobacter xylosoxidans in a 60-year-old male patient with end-stage renal failure receiving CAPD for 7 years, has been reported. White blood cell (WBC) count in peritoneal fluid was 3,160/mm3 with 95% neutrophil. Gram staining of the peritoneal fluid yielded gram negative rod. Empirical antibiotic therapy with ceftriaxone was initiated intraperitoneally. But drug sensitivity test revealed these regimens were resistant. On fourth hospital day, Achromobacter xylosoxidans was cultured from peritoneal effluent, the antibiotic regimen was switched to piperacillin/tazobactam intraperitoneally. The patient rapidly recovered and the WBC count of the peritoneal effluent decreased. The therapy was continued for 14 days and then the patient was discharged. The peritoneal catheter was not removed.
Bibliography:The Korean Society of Nephrology
G704-000889.2011.30.2.007
ISSN:2211-9132
2211-9140